Jerry A. Barbee Jr, PharmD, CPh

Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.

Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.

Prostate cancer is the leading cancer in men, with about 1 in 8 developing it in his lifetime.